INTELLIPHARMACEUTICS INTERNATIONAL INC. Proceeds from Other Equity
INTELLIPHARMACEUTICS INTERNATIONAL INC. reported Proceeds from Other Equity of $0 for the 12-month period ending 2019-11-30, per its 20-F filed 2020-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2020-03-30
- INTELLIPHARMACEUTICS INTERNATIONAL INC. proceeds from other equity for the quarter ending 2017-05-31 was 871.45K CAD, a 24.27% decline year-over-year.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. proceeds from other equity for the quarter ending 2017-02-28 was 577.02K CAD, a 45.26% increase year-over-year.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. proceeds from other equity for the quarter ending 2016-05-31 was 1.15M CAD.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. proceeds from other equity for the quarter ending 2016-02-29 was 397.24K CAD.
CAD
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 12 month |
|---|---|---|---|
| 2018-11-30 | 0.00 CAD 20-F · filed 2019-03-04 | ||
| 2017-11-30 | 2.54M CAD 20-F · filed 2019-03-04 | ||
| 2017-05-31 | 871.45K CAD 6-K · filed 2017-07-11 | 1.45M CAD 6-K · filed 2017-07-11 | |
| 2017-02-28 | 577.02K CAD 6-K · filed 2017-04-12 | ||
| 2016-11-30 | 3.47M CAD 20-F · filed 2019-03-04 | ||
| 2016-05-31 | 1.15M CAD 6-K · filed 2017-07-11 | 1.55M CAD 6-K · filed 2017-07-11 | |
| 2016-02-29 | 397.24K CAD 6-K · filed 2017-04-12 | ||
| 2015-11-30 | 1.29M CAD 20-F · filed 2018-03-01 | ||
| 2014-11-30 | 6.57M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 9 month | Proceeds from Other Equity 12 month |
|---|---|---|---|---|
| 2019-11-30 | $0.00 20-F · filed 2020-03-30 | |||
| 2018-11-30 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $0.00 20-F · filed 2020-03-30 |
| 2018-08-31 | $0.00 6-K · filed 2018-10-15 | $0.00 derived: sum of 2 quarters · filed 2018-10-15 | $0.00 6-K · filed 2018-10-15 | |
| 2018-05-31 | $0.00 6-K · filed 2018-07-24 | $0.00 6-K · filed 2018-07-24 | ||
| 2017-11-30 | $46.02K derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | $1.09M derived: sum of 2 quarters · filed 2020-03-30 | $1.96M derived: sum of 3 quarters · filed 2020-03-30 | $2.54M 20-F · filed 2020-03-30 |
| 2017-08-31 | $1.05M 6-K · filed 2018-10-15 | $1.92M derived: sum of 2 quarters · filed 2018-10-15 | $2.50M 6-K · filed 2018-10-15 | |
| 2017-05-31 | $871.45K 6-K · filed 2018-07-24 | $1.45M 6-K · filed 2018-07-24 | ||
| 2015-11-30 | $1.29M 20-F · filed 2016-03-21 | |||
| 2014-11-30 | $6.57M 20-F · filed 2016-03-21 |